Immobilized B7-H3/CD276 hFc Chimera, Human at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-B7-H3 Antibody, hFc Tag with the EC50 of 60.9 ng/ml determined by ELISA.

The purity of B7-H3/CD276 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

B7-H3/CD276 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

B7-H3/CD276 hFc Chimera, Human

B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.

产品编号	Z03881
规格	100 μg 500 μg 大单询价
数量
价格	￥2600


联系我们

产品简介

Species

Human

Protein Construction

B7-H3/CD276 (Leu29-Pro245) Accession # Q5ZPR3-2	hFc
N-term	C-term

Purity

> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC

Endotoxin Level

Less than 1EU per μg by the LAL method.

Biological Activity

Immobilized B7-H3/CD276 hFc Chimera, Human (Cat.No.: Z03881) at 2 μg/ml (100μl/Well) on the plate can bind Biotinylated Anti-B7-H3 Antibody, hFc Tag.

Expression System

HEK293

Theoretical Molecular Weight

50.1 kDa

Apparent Molecular Weight

Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.

Formulation

Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.

Reconstitution

It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O more than 100 μg/ml.

Storage & Stability

Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

图例

Immobilized B7-H3/CD276 hFc Chimera, Human at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Anti-B7-H3 Antibody, hFc Tag with the EC50 of 60.9 ng/ml determined by ELISA.

The purity of B7-H3/CD276 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

B7-H3/CD276 hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

技术背景

Target Background	B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.
Synonyms	B7H3; B7-H3; CD276; PSEC0249; UNQ309; PRO352; B7 homolog 3; CD276

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.